lasmiditan
Drug Details
- Generic Name
- lasmiditan
- Brand Names
- Reyvow
- Application Number
- NDA211280
- Sponsor
- Lilly del Caribe, Inc.
- NDC Codes
- 4
- Dosage Forms
- TABLET
- Routes
- ORAL
- Active Ingredients
- LASMIDITAN
Indications and Usage
1 INDICATIONS AND USAGE REYVOW ® is indicated for the acute treatment of migraine with or without aura in adults. REYVOW ® is a serotonin (5-HT) 1F receptor agonist indicated for the acute treatment of migraine with or without aura in adults. ( 1 ) Limitations of Use REYVOW is not indicated for the preventive treatment of migraine. ( 1 ) Limitations of Use REYVOW is not indicated for the preventive treatment of migraine.